PAVmed (PAVM) EBIT Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 34.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.85% |
| Sep 30, 2025 | 40.82% |
| Jun 30, 2025 | 41.44% |
| Mar 31, 2025 | 34.78% |
| Dec 31, 2024 | 35.88% |
| Jun 30, 2024 | -1.80% |
| Mar 31, 2024 | -20.23% |
| Dec 31, 2023 | -29.43% |
| Sep 30, 2023 | -41.10% |
| Jun 30, 2023 | -48.69% |
| Mar 31, 2023 | -57.19% |
| Dec 31, 2022 | -75.03% |
| Sep 30, 2022 | -93.13% |
| Jun 30, 2022 | -91.98% |
| Mar 31, 2022 | -84.15% |
| Dec 31, 2021 | -81.12% |
| Sep 30, 2021 | -74.58% |
| Jun 30, 2021 | -67.93% |
| Mar 31, 2021 | -60.77% |
| Dec 31, 2020 | -58.76% |
| Sep 30, 2020 | -41.10% |
| Jun 30, 2020 | -35.37% |
| Mar 31, 2020 | -34.56% |
| Dec 31, 2019 | -38.94% |
| Sep 30, 2019 | -18.92% |
| Jun 30, 2019 | -36.16% |
| Mar 31, 2019 | -65.24% |